The result indicated HCC patients with normal alpha-fetoprotein and with TGF-β1 reduction showed improvement in overall survival compared to patients with non-TGFβ1 reduction (NCT01246986) [76]. Here, TGFB1 is linked to hepatocellular carcinoma.